Prediction of stereotactic body radiotherapy for liver tumor using hypoxia imaging

Prediction of stereotactic body radiotherapy for liver tumor using hypoxia imaging - Prediction of liver stereotactic body radiotherapy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030279

Enrollment

Registered

2017-12-06

Start date

2017-11-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver tumors

Interventions

stereotactic body radiotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 liver tumors (5 cm or less) can receive stereotactic radiotherapy 2 medically inoperable or refusal of surgery 3 Performance status (ECOG) 0-2 4 20 years old or elder 5 written informed consent in the first-person (writing for the first-person on behalf of him/her is permitted)

Exclusion criteria

Exclusion criteria: 1. pregnancy or possible pregnancy 2. existence of severe systematic disease 3. Child-Pugh C 4. medical history of radiotherapy for upper abdomen 5. other (physician's decision)

Design outcomes

Primary

Measure	Time frame
two-year local control	—

Secondary

Measure	Time frame
overall survival, progression-free survival, local progression-free survival (local control), failure pattern, rate of completion of the treatment, incidence of toxicity, incidence of severe toxicity, volume of focal liver radiation damage and association of radiation-doses, validation among images, treatment planning, and images of image-guided radiotherapy, validation of set-up, intra-fraction, and inter-fraction errors, optimization of radiotherapy to minimize radiation exposure in radiotherapy, evaluation of accuracy of radiotherapy, differences between primary and metastatic liver tumors	—

Measure

Time frame

overall survival, progression-free survival, local progression-free survival (local control), failure pattern, rate of completion of the treatment, incidence of toxicity, incidence of severe toxicity, volume of focal liver radiation damage and association of radiation-doses, validation among images, treatment planning, and images of image-guided radiotherapy, validation of set-up, intra-fraction, and inter-fraction errors, optimization of radiotherapy to minimize radiation exposure in radiotherapy, evaluation of accuracy of radiotherapy, differences between primary and metastatic liver tumors

—

Countries

Japan

Contacts

Public ContactHiroshi Doi

Kindai University Faculty of Medicine Department of Radiation Oncology

h-doi@med.kindai.ac.jp072-366-0221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026